PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,243,000 | +2.4% | 147,303 | +6.2% | 0.52% | +22.2% |
| Q4 2019 | $1,214,000 | -37.7% | 138,729 | -20.6% | 0.43% | -42.5% |
| Q3 2019 | $1,949,000 | +20.7% | 174,641 | +37.5% | 0.74% | +25.5% |
| Q2 2019 | $1,615,000 | +3.7% | 127,029 | +71.9% | 0.59% | -14.2% |
| Q1 2019 | $1,558,000 | 0.0% | 73,876 | 0.0% | 0.69% | +3.6% |
| Q4 2018 | $1,558,000 | -13.3% | 73,876 | +88.4% | 0.67% | +8.1% |
| Q3 2018 | $1,796,000 | -12.2% | 39,209 | +8.0% | 0.62% | -18.5% |
| Q2 2018 | $2,045,000 | +14.6% | 36,297 | +38.4% | 0.76% | +3.0% |
| Q1 2018 | $1,785,000 | +21.1% | 26,229 | +75.9% | 0.73% | +15.2% |
| Q4 2017 | $1,474,000 | -17.4% | 14,909 | 0.0% | 0.64% | -20.1% |
| Q3 2017 | $1,785,000 | +8.2% | 14,909 | -21.0% | 0.80% | +6.1% |
| Q2 2017 | $1,650,000 | +69.9% | 18,874 | -27.7% | 0.75% | +94.1% |
| Q1 2017 | $971,000 | +767.0% | 26,105 | +1649.7% | 0.39% | +578.9% |
| Q3 2015 | $112,000 | -35.6% | 1,492 | 0.0% | 0.06% | -27.8% |
| Q2 2015 | $174,000 | -50.6% | 1,492 | 0.0% | 0.08% | -50.9% |
| Q1 2015 | $352,000 | – | 1,492 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |